ZA9810468B - Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof - Google Patents

Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof

Info

Publication number
ZA9810468B
ZA9810468B ZA9810468A ZA9810468A ZA9810468B ZA 9810468 B ZA9810468 B ZA 9810468B ZA 9810468 A ZA9810468 A ZA 9810468A ZA 9810468 A ZA9810468 A ZA 9810468A ZA 9810468 B ZA9810468 B ZA 9810468B
Authority
ZA
South Africa
Prior art keywords
inhibition
preparation
pharmaceutical compositions
heterocyclic compounds
gastric acid
Prior art date
Application number
ZA9810468A
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA9810468B publication Critical patent/ZA9810468B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9810468A 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof ZA9810468B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Publications (1)

Publication Number Publication Date
ZA9810468B true ZA9810468B (en) 1999-05-21

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810468A ZA9810468B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof

Country Status (33)

Country Link
US (1) US6518270B1 (es)
EP (1) EP1042324B1 (es)
JP (1) JP2001525322A (es)
KR (1) KR20010032559A (es)
CN (1) CN1142933C (es)
AR (1) AR016972A1 (es)
AT (1) ATE233263T1 (es)
AU (1) AU752187C (es)
BR (1) BR9814755A (es)
CA (1) CA2311798A1 (es)
CZ (1) CZ292349B6 (es)
DE (1) DE69811735T2 (es)
DK (1) DK1042324T3 (es)
EE (1) EE04060B1 (es)
ES (1) ES2191356T3 (es)
HK (1) HK1030216A1 (es)
HU (1) HUP0100601A3 (es)
ID (1) ID24730A (es)
IL (1) IL136145A0 (es)
IS (1) IS5486A (es)
MY (1) MY121032A (es)
NO (1) NO315704B1 (es)
NZ (1) NZ504355A (es)
PL (1) PL340920A1 (es)
PT (1) PT1042324E (es)
RU (1) RU2241000C2 (es)
SE (1) SE9704404D0 (es)
SK (1) SK283904B6 (es)
TR (1) TR200001530T2 (es)
TW (1) TW515798B (es)
UA (1) UA70932C2 (es)
WO (1) WO1999028322A1 (es)
ZA (1) ZA9810468B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1463097A (en) 1996-01-04 1997-08-01 Rican Limited Helicobacter pylori bacterioferritin
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
AU773218B2 (en) * 1999-10-08 2004-05-20 Debiopharm International Sa Fab I inhibitors
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
US6919340B2 (en) 2002-04-19 2005-07-19 Cellular Genomics, Inc. Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
WO2004022562A1 (en) 2002-09-09 2004-03-18 Cellular Genomics, Inc. 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
AU2003266621A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for treatment for or prevention of visceral pain
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
JP4859460B2 (ja) * 2002-12-06 2012-01-25 アフィニウム ファーマシューティカルズ， インク． ヘテロ環化合物、その製造方法および治療におけるその使用
WO2004072081A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
CA2519429C (en) * 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US7405295B2 (en) 2003-06-04 2008-07-29 Cgi Pharmaceuticals, Inc. Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
US7393848B2 (en) 2003-06-30 2008-07-01 Cgi Pharmaceuticals, Inc. Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
US7259164B2 (en) 2003-08-11 2007-08-21 Cgi Pharmaceuticals, Inc. Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
KR102152809B1 (ko) * 2004-07-28 2020-09-07 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
CA2575345A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
US8148529B2 (en) 2004-09-03 2012-04-03 Yuhan Corporation Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof
KR100958830B1 (ko) 2004-09-03 2010-05-24 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
ES2342478T3 (es) * 2004-09-03 2010-07-07 Yuhan Corporation Derivados de pirrolo(3,2-c)piridina y procedimiento para la preparacion de los mismos.
BRPI0514695A (pt) 2004-09-03 2008-06-17 Yuhan Corp derivados de pirrol[3, 2-b]piridina e processos para a preparação destes
WO2007024294A2 (en) 2005-05-03 2007-03-01 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
CA2620223A1 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
CA2632476A1 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
CA2654202A1 (en) * 2006-06-06 2007-12-21 Schering Corporation Imidazopyrazines as protein kinase inhibitors
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
EP2252617A1 (en) 2008-02-13 2010-11-24 CGI Pharmaceuticals, Inc. 6-aryl-imidaz0[l, 2-a]pyrazine derivatives, method of making, and method of use thereof
KR20170013414A (ko) 2008-12-08 2017-02-06 질레드 코네티컷 인코포레이티드 이미다조피라진 ｓｙｋ 억제제
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
JP5696052B2 (ja) 2008-12-08 2015-04-08 ギリアード コネチカット， インコーポレイテッド イミダゾピラジンｓｙｋ阻害剤
US9562056B2 (en) 2010-03-11 2017-02-07 Gilead Connecticut, Inc. Imidazopyridines Syk inhibitors
WO2013190384A1 (en) 2012-06-19 2013-12-27 Affinium Pharmaceuticals, Inc. Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
PE20160605A1 (es) 2013-07-30 2016-07-20 Gilead Connecticut Inc Formulaciones de inhibidores de la syk
NZ715776A (en) 2013-07-30 2017-04-28 Gilead Connecticut Inc Polymorph of syk inhibitors
PT3076976T (pt) 2013-12-04 2020-12-07 Kronos Bio Inc Métodos para tratar cancros
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
TWI735853B (zh) 2013-12-23 2021-08-11 美商克洛諾斯生技有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
AU2015290000B2 (en) 2014-07-14 2018-05-17 Gilead Sciences, Inc. Combinations for treating cancers
MX2018010254A (es) 2016-02-26 2018-12-19 Debiopharm Int Sa Medicamento para el tratamiento de infecciones de pie diabetico.
WO2019040298A1 (en) 2017-08-25 2019-02-28 Gilead Sciences, Inc. SYK INHIBITORY POLYMORPHS
MX2021010131A (es) 2019-02-22 2021-11-18 Kronos Bio Inc Formas sólidas de pirazinas condensadas a manera de inhibidores de syk.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
WO1991017164A1 (de) 1990-04-27 1991-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue pyridazine
US5041442A (en) * 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
WO1992006979A1 (de) 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
DE59209687D1 (de) 1991-10-25 1999-06-02 Byk Gulden Lomberg Chem Fab Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
EP0742218B1 (en) * 1994-01-19 2002-12-04 Sankyo Company Limited Pyrrolopyridazine derivative
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
NO315704B1 (no) 2003-10-13
DK1042324T3 (da) 2003-05-05
EE04060B1 (et) 2003-06-16
CN1142933C (zh) 2004-03-24
EP1042324B1 (en) 2003-02-26
NZ504355A (en) 2001-12-21
PL340920A1 (en) 2001-03-12
SK283904B6 (sk) 2004-04-06
MY121032A (en) 2005-12-30
PT1042324E (pt) 2003-06-30
UA70932C2 (uk) 2004-11-15
CN1284078A (zh) 2001-02-14
CA2311798A1 (en) 1999-06-10
ATE233263T1 (de) 2003-03-15
BR9814755A (pt) 2000-10-03
HK1030216A1 (en) 2001-04-27
IL136145A0 (en) 2001-05-20
CZ20001947A3 (cs) 2000-11-15
AU752187C (en) 2003-09-18
RU2241000C2 (ru) 2004-11-27
DE69811735T2 (de) 2003-12-18
WO1999028322A1 (en) 1999-06-10
US6518270B1 (en) 2003-02-11
KR20010032559A (ko) 2001-04-25
NO20002721D0 (no) 2000-05-26
IS5486A (is) 2000-05-10
SE9704404D0 (sv) 1997-11-28
NO20002721L (no) 2000-07-28
CZ292349B6 (cs) 2003-09-17
TW515798B (en) 2003-01-01
HUP0100601A2 (hu) 2001-09-28
HUP0100601A3 (en) 2002-10-28
EE200000315A (et) 2001-10-15
SK6742000A3 (en) 2001-03-12
ID24730A (id) 2000-08-03
AR016972A1 (es) 2001-08-01
TR200001530T2 (tr) 2000-11-21
EP1042324A1 (en) 2000-10-11
DE69811735D1 (de) 2003-04-03
AU752187B2 (en) 2002-09-12
AU1356599A (en) 1999-06-16
ES2191356T3 (es) 2003-09-01
JP2001525322A (ja) 2001-12-11

Similar Documents

Publication Publication Date Title
ZA9810468B (en) Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof
HK1024248A1 (en) Compounds for inhibition of gastric acid secretion
IL116957A0 (en) Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
HUP0101580A3 (en) Pharmaceutical compositions capable of being gelled
IL129477A0 (en) N-(aryl/heteroaryl)amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
HUP0000492A3 (en) N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HUP0105160A3 (en) Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-betha-cyclodextrin or 2-hydroxypropyl-betha-cyclodextrin and method for its preparation and pharmaceutical compositions containing them
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
IL141165A0 (en) New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
SI1105391T1 (en) Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
IL114534A (en) Heterocyclic derivatives of azolones their preparation and pharmaceutical compositions containing them
GB2355657B (en) Inhibitors Of Gastric Acid Secretion
HUP0103134A2 (en) Process for preparation crystalline forms of osanetant and pharmaceutical compositions containing them
SI1042324T1 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
IL123424A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
HUP0001441A3 (en) Process for the preparation of pharmaceutical compositions containing 4-aza-androst-1-ene derivatives
ZA94368B (en) Amino acid derivatives pharmaceutical compositions containing these compound and processes for their preparation
IL116285A0 (en) Compounds for inhibition of gastric acid secretion
AU4527900A (en) Inhibition of gastric acid production and/or secretion
AU1748001A (en) Pharmaceutical composition for treatment of diarrhea
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
IL114621A0 (en) Derivatives of 6-fluoro-8-difluoromethoxy-substituted quinolonecarboxylic acids theit preparation and pharmaceutical compositions containing them